This article explores Alcoholic Fatty Liver Disease (AFLD) and its prevalent comorbidities. It also emphasises on the necessity for an all-encompassing strategy for diagnosis and treatment as shown by actual case studies.

---

Alcoholic fatty liver disease (AFLD) is a common liver condition that affects individuals with a history of heavy alcohol consumption. While AFLD itself can be a significant health concern, it often occurs alongside various comorbidities, complicating the clinical picture and management.

In this article, we will explore AFLD and its frequently associated comorbidities, highlighting the importance of a comprehensive approach to diagnosis and treatment. This information is essential for general practitioners, surgeons, and specialists to provide effective care to patients with AFLD.

---

Understanding Alcoholic Fatty Liver Disease (AFLD)

AFLD is characterised by the accumulation of fat in liver cells due to excessive alcohol consumption. It typically presents in three stages:

• Alcoholic fatty liver
• Alcoholic hepatitis
• Alcoholic cirrhosis

The prevalence of AFLD is increasing worldwide, making it a major public health concern.

---

Diagnosis and assessment

1. Clinical history: Begin with a thorough patient history, focusing on alcohol consumption patterns.
2. Imaging: Ultrasound, CT scans, or MRI can detect fatty liver changes.
3. Liver function tests: Serum aminotransferases, gamma-glutamyl transferase (GGT), and bilirubin levels may be elevated.
4. Biopsy: Liver biopsy provides a definitive diagnosis and assesses the extent of liver damage, but it is invasive and less frequently used today.

---

Common comorbidities associated with AFLD

1. Obesity: Obesity and AFLD often coexist. Both conditions contribute to insulin resistance and inflammation, worsening liver damage.
2. Diabetes mellitus: AFLD increases the risk of developing type 2 diabetes due to insulin resistance and impaired glucose metabolism.
3. Cardiovascular disease: Patients with AFLD have a higher risk of cardiovascular events, emphasising the need for cardiovascular risk assessment and management.
4. Hypertension: Hypertension is common in individuals with AFLD, and its presence should prompt aggressive blood pressure control.
5. Dyslipidemia: AFLD can lead to abnormal lipid profiles, which may necessitate lipid-lowering therapy.
6. Hepatitis C: Co-infection with hepatitis C virus (HCV) can accelerate liver damage in AFLD patients, requiring appropriate antiviral therapy.

---

Approach to diagnosis and management

Lifestyle modification

1. Abstinence from alcohol is the cornerstone of AFLD management. Offer support and referral to addiction services as needed.
2. Encourage weight loss through diet and exercise, which can improve insulin sensitivity and reduce liver fat.

Pharmacological interventions

1. Vitamin E supplementation may be considered in some cases to reduce liver inflammation.
2. For patients with obesity and diabetes, medications like metformin may help manage these comorbidities.

Cardiovascular risk assessment

1. Assess and manage cardiovascular risk factors, including blood pressure, lipid profiles, and blood glucose levels.
2. Promote a heart-healthy lifestyle, including smoking cessation and regular exercise.

Hepatitis C screening

1. Screen all AFLD patients for hepatitis C infection.
2. Treat co-infected individuals with appropriate antiviral therapy.

Regular monitoring

1. Regular follow-up appointments and liver function tests are crucial for tracking progress and addressing complications promptly.
2. AFLD is a serious liver condition often accompanied by a range of comorbidities, including obesity, diabetes, cardiovascular disease, and hypertension.
3. General practitioners, surgeons, and specialists must take a comprehensive approach to diagnose and manage AFLD effectively.
4. This approach involves alcohol cessation, lifestyle modification, pharmacological interventions, cardiovascular risk assessment, and hepatitis C screening.
5. Early intervention and a multidisciplinary approach are essential to prevent disease progression and improve patient outcomes. By addressing both AFLD and its comorbidities, healthcare providers can significantly impact their patients' health and well-being.

---

Case studies

1. AFLD with diabetes and cardiovascular disease

A 55-year-old male presented with a history of heavy alcohol consumption and recent complaints of fatigue, abdominal discomfort, and elevated liver enzymes. His medical history included type 2 diabetes and hypertension.

Diagnosis and management

1. AFLD was diagnosed through clinical history, imaging, and liver function tests. The patient was referred to an addiction specialist for alcohol cessation support. A comprehensive assessment revealed poorly controlled diabetes and uncontrolled blood pressure.
2. Medications for diabetes, hypertension, and lipid-lowering therapy were initiated. Regular follow-up appointments included monitoring liver function, cardiovascular risk factors, and glycemic control.

---

2. AFLD with obesity and hepatitis C co-infection

Patient profile

A 42-year-old female, presented with complaints of persistent fatigue, abdominal pain, and irregular liver function tests. She had a history of heavy alcohol use, obesity, and a recent diagnosis of hepatitis C.

Diagnosis and management

1. AFLD was confirmed through imaging and liver biopsy. The patient was referred to a hepatologist for evaluation of hepatitis C infection.
2. A comprehensive approach involved alcohol cessation, weight loss counselling, and antiviral therapy for hepatitis C.
3. Nutritional counselling was initiated to address obesity-related concerns.

Disclaimer- The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of M3 India.